Does EMPAGLIFLOZIN Cause Diabetic ketoacidosis? 3,644 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,644 reports of Diabetic ketoacidosis have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 9.8% of all adverse event reports for EMPAGLIFLOZIN.
3,644
Reports of Diabetic ketoacidosis with EMPAGLIFLOZIN
9.8%
of all EMPAGLIFLOZIN reports
85
Deaths
2,610
Hospitalizations
How Dangerous Is Diabetic ketoacidosis From EMPAGLIFLOZIN?
Of the 3,644 reports, 85 (2.3%) resulted in death, 2,610 (71.6%) required hospitalization, and 642 (17.6%) were considered life-threatening.
Is Diabetic ketoacidosis Listed in the Official Label?
Yes, Diabetic ketoacidosis is listed as a known adverse reaction in the official FDA drug label for EMPAGLIFLOZIN.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
Acute kidney injury (1,023)
What Other Drugs Cause Diabetic ketoacidosis?
CANAGLIFLOZIN (3,413)
DAPAGLIFLOZIN (1,773)
METFORMIN (1,584)
INSULIN ASPART (1,398)
INSULIN LISPRO (924)
INSULIN GLARGINE (776)
NIVOLUMAB (687)
DAPAGLIFLOZIN PROPANEDIOL (547)
PEMBROLIZUMAB (397)
IPILIMUMAB (358)
Which EMPAGLIFLOZIN Alternatives Have Lower Diabetic ketoacidosis Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE